Recent developments to share with you

【Visit Kangchuanji】 – Together We Sail, Together We Prevail

2022-09-12


Under a clear blue sky and a cool autumn breeze, Kangchuanji held the “Visit Kangchuanji” open house on the afternoon of November 10, taking the opportunity of the QianTuhui National Pharmaceutical R&D and Manufacturing Outsourcing Cooperation Conference held in Nanjing. We sincerely invited more than 20 colleagues from the pharmaceutical industry to visit and exchange ideas.

The event began with Ms. Zhu Chunli, Deputy General Manager of the company, giving a comprehensive presentation on our R&D strategy, R&D environment, project experience, and management. She then led the guests to tour the laboratory facilities and introduced the company's ongoing projects.

  

 

“Professionalism builds quality; innovation leads the future”– this is the core philosophy we always uphold. Our mission is to “improve the formulation technology level of Chinese pharmaceutical manufacturers and help Chinese companies master core formulation technologies.” With our integrated, full-service open platform and our experience in areas such as improved new drugs, we continuously explore and drive the development of the domestic pharmaceutical and healthcare industry.

The pharmaceutical industry is currently going through a difficult transformation period, but Kangchuanji believes that the temporary pains of transformation will eventually pass, and the future of the industry will be bright. As a famous poem says: “Don't let complaints break your heart; take a broad view of the long run. Don’t say Kunming Lake is too shallow; watching fish there beats the Fuchun River.”

Alone, one can hardly overcome difficulties; together, we can achieve great things. The visit and exchange event concluded successfully in a warm and joyful atmosphere. Through on site visits, special presentations, and interactive Q&A sessions, our colleagues from the industry gained a deeper understanding of Kangchuanji. Let us work together, ride the winds and waves, overcome obstacles, and tackle challenges shoulder to shoulder. We look forward to further cooperation and exchanges with you all in the future!

 

Keywords:

Related information

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

2026-07-03

Good News | Kangchuanji Pharmaceutical’s Sildenafil Citrate Orally Disintegrating Tablets Have Been Approved for Market Launch

According to the drug approval document delivery information released by the NMPA, sildenafil citrate orally disintegrating tablets manufactured by Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. have been approved for marketing as a Class 4 generic drug under the new chemical drug registration classification, and are deemed to have passed the consistency evaluation.

2026-06-29

A Strong Start to the New Year – Kangchuanji Achieves Multiple Approvals

The new year begins with a wave of good news. Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. has made an excellent start, backed by professional expertise. According to NMPA drug approval information, the following products have been approved for marketing or have passed consistency evaluation: Famotidine Injection (2ml:20mg), Saxagliptin and Metformin Hydrochloride Extended-Release Tablets (2.5/1000mg and 5/1000mg), Isosorbide Dinitrate Tablets (5mg), Vitamin B6 Injection (100mg/ml), Cefdinir Granules (50mg/0.5g), and Ambroxol and Clenbuterol Oral Solution (1ml: ambroxol hydrochloride 1.5mg and clenbuterol hydrochloride 1μg). Among these, Isosorbide Dinitrate Tablets are the first in China to pass consistency evaluation. As a partner, Kangchuanji provided solid pharmaceutical R&D services, successfully supporting these drugs through the review and approval process.

2026-03-23